Leukemia Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Not yet recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
2022-04-04
Apr 4, 2022
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2022-03-22
Mar 22, 2022
D
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Coral Gables, Florida
  • +8 more
2022-03-10
Mar 10, 2022
C
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
C
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
2022-03-03
Mar 3, 2022
B
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +92 more
2022-02-24
Feb 24, 2022
I
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +107 more
2022-02-22
Feb 22, 2022
M
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
2022-02-07
Feb 7, 2022
H
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
Recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
2022-01-26
Jan 26, 2022
M
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
2022-01-21
Jan 21, 2022
M
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
2021-12-28
Dec 28, 2021
D
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
Recruiting
  • Leukemia
  • +2 more
  • Genomic profiling
  • Boston, Massachusetts
  • +2 more
2021-12-03
Dec 3, 2021
A
A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia - 2021
Completed
  • Leukemia
  • +2 more
  • Boston, Massachusetts
  • +14 more
2021-11-19
Nov 19, 2021
M
CAR-37 T Cells In Hematologic Malignancies
Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021
N
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
2021-10-14
Oct 14, 2021
D
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
Recruiting
  • Leukemia
  • Boston, Massachusetts
  • +1 more
2021-08-23
Aug 23, 2021
A
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +175 more
2021-08-16
Aug 16, 2021
A
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Active, not recruiting
Has Results
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
2021-08-16
Aug 16, 2021
A
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
  • Leukemia
  • +2 more
  • laboratory biomarker analysis
  • San Diego, California
  • +50 more
2021-08-16
Aug 16, 2021
D
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
Recruiting
  • Leukemia
  • Boston, Massachusetts
  • +1 more
2021-08-02
Aug 2, 2021
A
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Active, not recruiting
  • Leukemia
  • DNA analysis
  • +3 more
  • San Diego, California
  • +160 more
2021-07-19
Jul 19, 2021
D
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
2021-06-16
Jun 16, 2021
C
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia - 2020
Completed
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +197 more
2021-03-22
Mar 22, 2021
M
AZD6738 for Patients With Progressive MDS or CMML
Recruiting
  • Leukemia
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +3 more
2021-01-13
Jan 13, 2021
N
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies - 2009
Completed
Has Results
  • Lymphoma
  • +2 more
  • Augusta, Georgia
  • +6 more
2020-12-16
Dec 16, 2020